ClinConnect ClinConnect Logo
Search / Trial NCT05950438

Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

Launched by NORTHWESTERN UNIVERSITY · Jul 11, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Robotic Transhiatal

ClinConnect Summary

This clinical trial is studying a surgical procedure called robotic transhiatal esophagectomy, which involves removing part or all of the esophagus, the tube that connects your throat to your stomach. The main goal of the study is to gather information about how this surgery affects patients both in the short term and long term. Researchers want to understand the health outcomes after the surgery by looking at data collected before, during, and after the procedure.

To be eligible to participate in this trial, you need to be an adult (18 years or older) who is having this surgery for planned reasons (not an emergency). You may also participate if you have previously had this surgery. However, if you're pregnant, a minor, unable to give consent, or part of a vulnerable group, you won't be able to join. If you do participate, you can expect to be involved in monitoring your health results related to the surgery over time. This study aims to help improve patient care for future surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients (18 years or older)
  • Patients undergoing elective esophagectomy for any indication
  • Patients who have already had an elective esophagectomy for any indication
  • Patients with consent providing capacity
  • Exclusion Criteria:
  • Patients undergoing emergent esophagectomy
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Vulnerable Populations

About Northwestern University

Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Ankit Bharat, MD

Principal Investigator

Northwestern University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported